Gene: SYT1
Official Full Name: synaptotagmin 1provided by HGNC
Gene Summary: This gene encodes a member of the synaptotagmin protein family. The synaptotagmins are integral membrane proteins of synaptic vesicles that serve as calcium sensors in the process of vesicular trafficking and exocytosis. The encoded protein participates in triggering neurotransmitter release at the synapse in response to calcium binding. Mutations in this gene are associated with Baker-Gordon syndrome. [provided by RefSeq, Jan 2023]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35156 | SYT1 Knockout cell line (HCT 116) | Human | SYT1 | 1:2~1:4 | Negative | Online Inquiry |
KO35157 | SYT1 Knockout cell line (HEK293) | Human | SYT1 | 1:3~1:6 | Negative | Online Inquiry |
KO35158 | SYT1 Knockout cell line (A549) | Human | SYT1 | 1:3~1:4 | Negative | Online Inquiry |
SYT1 Gene Knockout Cell Lines are genetically modified cellular systems designed to facilitate the study of the SYT1 gene, which encodes for synaptotagmin-1, a key protein involved in neurotransmitter release and synaptic function. These knockout cell lines have been precisely engineered to disrupt the normal function of the SYT1 gene, allowing researchers to explore the role of this protein in cellular signaling pathways related to synaptic transmission.
The key function of SYT1 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for investigating the mechanisms behind synaptic vesicle exocytosis and neuronal communication. By eliminating the SYT1 protein, researchers can directly observe the resulting physiological and biochemical changes, including alterations in calcium dependency, neurotransmitter release dynamics, and signal transduction pathways. This makes the cell lines an invaluable tool for dissecting the underpinnings of various neurological disorders and developing targeted therapies.
In a research context, these knockout cell lines can be pivotal for studies into neurodegenerative diseases, psychiatric disorders, and synaptic dysfunctions, offering insights that are critical for advancing our understanding of the human brain. In clinical settings, they support the evaluation of potential therapeutics aimed at modulating synaptic activity, presenting a roadmap for drug development.
The advantages of SYT1 Gene Knockout Cell Lines over traditional approaches include their specificity in targeting the SYT1 gene, coupled with a reliable and reproducible methodology that minimizes off-target effects. Additionally, these cell lines provide a flexible platform for high-throughput screening, enabling rapid assessment of drug candidates in a controlled genomic context.
For researchers and clinicians, the value of SYT1 Gene Knockout Cell Lines is evident in their ability to bridge fundamental neuroscience research with clinical application. By providing a comprehensive tool for the dissection of synaptic mechanisms and potential therapeutic interventions, these cell lines enhance our collective understanding of neural function.
Our company is dedicated to advancing biological research through innovative product offerings, ensuring that researchers have access to the highest quality tools necessary for groundbreaking discoveries in neuroscience and beyond. With a commitment to excellence and support, we empower our users to push the boundaries of scientific inquiry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.